Tulip Lab Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
CIN U51397MH2004PTC414474 Incorporated 11 March 2004 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Private Limited Company pharma MSME · Small
Data last updated
Revenue · FY 2023
₹38.12 Cr
▼ 78% YoY
Net profit · FY 2023
₹1.12 Cr
Net margin 2.9%
EBITDA · FY 2023
₹2.93 Cr
EBITDA margin 7.7%
Authorised capital
₹6 Cr
Registered with MCA
Paid-up capital
₹4.96 Cr
Issued & subscribed
Open charges
₹39.64 Cr
Satisfied ₹212.53 Cr
Company age
22 yrs
Est. 2004
Employees · EPFO
75
Provident fund records

About Tulip Lab Private Limited

Data last updated:

Tulip Lab Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 11 March 2004 and has been in existence for over 22 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U51397MH2004PTC414474. Its GSTIN is 27AACCT0325L1ZE (Maharashtra). The company holds 7 GST registrations, of which 1 is active.

The company has an authorised share capital of ₹6 Cr and a paid-up capital of ₹4.96 Cr. It is led by directors including Tushar Kumar and Rajni Rahul Pandey.

Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at Mumbai, Maharashtra.

As per the financials filed for FY 2023, the company reported a revenue of ₹38.12 Cr, a decline of 78% compared to the previous year. For the same year it recorded a net profit of ₹1.12 Cr (net margin 2.9%) and EBITDA of ₹2.93 Cr (EBITDA margin 7.7%). Revenue has grown at a compounded annual rate (CAGR) of 6% over three years and 9% over five years.

The company has about 75 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: Tulip Lab. As per MCA filings, the company has open charges of ₹39.64 Cr and satisfied charges of ₹212.53 Cr on record. Court records list 13 cases involving the company, including 8 filed by the company and 5 filed against it; 6 cases are pending. The company has 3 deals on record (1 rights issue, 1 funding round, 1 secondary share transfer), with disclosed funding of ₹7.99 Cr; the latest was in March 2023. Its 7 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 3 smaller; the largest is Bio Medica Laboratories Limited with revenue of ₹38.33 Cr. The company has 5 MSME Form 1 returns on record between 2019 and 2022, listing 36 overdue payments to 22 micro and small suppliers.

Tulip Lab Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-18-0126278). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website tuliplab.com.

Company details

CIN U51397MH2004PTC414474
Registration Number 414474
Incorporation Date 11 March 2004
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2023
Date of Balance Sheet 31 March 2023
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-MH-18-0126278

CIN history

Tulip Lab has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U51397MH2004PTC414474, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U51397MH2004PTC414474Current
U51397BR2004PTC010634Previous
U00093BR2004PTC010634Previous

Recognitions & Rankings of Tulip Lab

MSME (Udyam registered) Ministry of MSME
Category
Small (2024-25)
Udyam number
UDYAM-MH-18-0126278

Contact details

Tulip Lab Private Limited's registered office is in Mumbai, Maharashtra. Its website is tuliplab.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Social Media
  • Registered Address
    Gala 3067 Oberoi Garden, Saki Naka Road Near Chandivali Studio, Mumbai, Maharashtra, India – 400072
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Tulip Lab Private Limited, buy the company report.

Comprehensive company report
Tulip Lab Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Tulip Lab operates one associated brand: Tulip Lab. Each brand links to its own profile.

BrandDescriptionWebsite
Pharmaceutical manufacturing, herbal products, and clinical research services in India.tuliplab.com

Business activity

The main business activity of Tulip Lab is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Tulip Lab Private Limited, buy the company report.

Financials of Tulip Lab Private Limited

FY 2023 filings available

Tulip Lab Private Limited reported revenue of ₹38.12 Cr (down 78% YoY) for FY 2023.

Revenue · FY 2023
₹38.12 Cr ▼ 78%
Net profit · FY 2023
₹1.12 Cr margin 2.9%
EBITDA · FY 2023
₹2.93 Cr margin 7.7%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 78%
3 years · compounded
▲ 6%
5 years · compounded
▲ 9%
EBITDA CAGR growth
1 year
▲ 133%
3 years · compounded
▲ 37%
5 years · compounded
▲ 19%

Revenue fell 78% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 9%. EBITDA rose 133% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2022-23FY 2021-22FY 2020-21FY 2019-20FY 2018-19
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹2.93 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹1.12 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2022-23FY 2021-22FY 2020-21FY 2019-20FY 2018-19
Profitability
EBITDA Margin7.7%
Net Profit Margin2.9%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Tulip Lab Private Limited, buy the company report.

Board of directors of Tulip Lab Private Limited

Tulip Lab has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Tushar KumarDirector11 Mar 200422 Years 7 MonthsCurrent
Rajni Rahul PandeyDirector30 Mar 20215 Years 6 MonthsCurrent
Prashant SinghDirector11 Mar 200422 Years 7 MonthsCurrent

Peer comparison

Tulip Lab Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Bio Medica Laboratories Limited₹38.33 Cr (FY 2025)150.0%Indore, Madhya Pradesh, India
Medicamen Organics Limited.₹38.28 Cr (FY 2025)51.0%New Delhi, Delhi, India
Diamond Drugs Private Limited₹38.26 Cr (FY 2024)2.0%Kolkata, West Bengal, India
Klar Sehen Pvt Ltd₹38.16 Cr (FY 2016)18.0%Bidar, Karnataka, India
Tulip Lab Private Limitedthis company₹38.12 Cr (FY 2023)₹1.12 Cr2.9%-78.0%75Mumbai, Maharashtra, India
Biomax Biotechnics Private Limited₹38.1 Cr (FY 2025)9.0%Chandigarh, India
Zivira Labs Private Limited₹38.07 Cr (FY 2025)22.0%Mumbai, Maharashtra, India
VVR Organics Private Limited₹38.01 Cr (FY 2024)9.0%Hyderabad, Telangana, India

To see the full peer comparison of Tulip Lab Private Limited, buy the company report.

Auditor

Tulip Lab Private Limited is audited by Y R & Associates for the financial year 2022.

Auditor firmFinancial yearFirm registration number
Y R & AssociatesFY 2022135722W

Shareholding

The shareholding of Tulip Lab Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2022FY 2021FY 2020FY 2019FY 2018
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Tulip Lab Private Limited, buy the company report.

Charges & borrowings

Open charges
₹39.64 Cr
Satisfied charges
₹212.53 Cr
Breakdown by lending institutions
Others₹30.00 Cr
Hdfc Bank Limited₹9.64 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
07 Aug 2025101158681Others₹15 CrOpen
15 Mar 2024100890228Others₹15 CrOpen
10 Jul 2023100772728Hdfc Bank Limited₹9.64 CrOpen
20 Jul 2022100606729Others₹80 CrSatisfied
14 Mar 2022100557404Hdfc Bank Limited₹8 CrSatisfied

To see the full charge records of Tulip Lab Private Limited, buy the company report.

Total charge records: 11 View all charges

Deals & funding

Tulip Lab Private Limited has 3 deals on record (1 rights issue, 1 funding round, 1 secondary share transfer), with disclosed funding of ₹7.99 Cr; the latest was in March 2023.

Total deals
3
Rights issue
1
Funding round
1
Secondary share transfer
1
Disclosed funding
₹7.99 Cr

Deals on record (3 of 3)

WhenDealAmountParties
Mar 2023Funding round · Series A₹7.99 CrInvestors: 2 individuals
Mar 2020Rights issue₹3.98 CrInvestors: 2 individuals
Mar 2008Secondary share transferUndisclosedBuyer: 3 individuals
Seller: 2 individuals

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

Tulip Lab Private Limited has 5 MSME Form 1 returns on record between 2019 and 2022, listing 36 overdue payments to 22 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 22)

SupplierAmount dueDue sinceReported on
Thermolab Testing Services Private Limited
an individual supplier
Y R & Associates
Envirocare Labs Private Limited
Ideal Cures Private Limited

To see the full MSME payment records of Tulip Lab Private Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

Employees & EPFO

Tulip Lab Private Limited has a workforce of 75 employees on its EPFO records as of Apr 05, 2024, across 1 active EPFO establishment.

Employee count
75
Active EPFO establishments
1
Employee growth
15.38%

GST

Tulip Lab has 7 GST registrations: 1 active and 6 cancelled or inactive.

Total GSTINs
7
Active
1
Cancelled / inactive
6
GSTINStateStatusRegistered on
27AACCT0325L1ZEMaharashtraActive01 Jul 2017

To see the full GST registrations and return filing status of Tulip Lab Private Limited, buy the company report.

Recent activity

Tulip Lab Private Limited has 5 board changes on record since 2004: 3 appointments and 2 cessations. The latest: Rajni Rahul Pandey ceased to be Additional Director on 30 Nov 2021.

Charges
A charge with Others amounted to Rs. 15.00 Cr with Charge ID 101158681 was registered on 07 Aug 2025.
Charges
A charge with Others of Rs. 15.00 Cr registered on 15 Mar 2024 with Charge ID 100890228 was modified on 07 Aug 2025.
Charges
A charge registered on 14 Mar 2022 via Charge ID 100557404 with Hdfc Bank Limited was fully satisfied on 19 Mar 2024.
Charges
A charge with Others amounted to Rs. 15.00 Cr with Charge ID 100890228 was registered on 15 Mar 2024.
Charges
A charge registered on 20 Jul 2022 via Charge ID 100606729 with Others was fully satisfied on 23 Oct 2023.
AGM
Tulip Lab Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
Charges
A charge with Hdfc Bank Limited of Rs. 9.64 Cr registered on 10 Jul 2023 with Charge ID 100772728 was modified on 14 Sep 2023.
Charges
A charge with Others of Rs. 80.00 Cr registered on 20 Jul 2022 with Charge ID 100606729 was modified on 08 Aug 2023.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 9.64 Cr with Charge ID 100772728 was registered on 10 Jul 2023.
Filing
Tulip Lab Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Mumbai.
Charges
A charge with Hdfc Bank Limited of Rs. 8.00 Cr registered on 14 Mar 2022 with Charge ID 100557404 was modified on 21 Oct 2022.
Charges
A charge registered on 13 Dec 2014 via Charge ID 10544838 with Hdfc Bank Limited was fully satisfied on 22 Jul 2022.

20 earlier events are in the company report.

Frequently asked questions

Tulip Lab is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 11 March 2004 (22+ years old) and is registered under CIN U51397MH2004PTC414474.

Tulip Lab has 3 current directors:

The latest financial statements of Tulip Lab on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from 2015 are in the company report.

The GSTIN of Tulip Lab is 27AACCT0325L1ZE, registered in Maharashtra. The company has 7 GST registrations in all, of which 1 is active and 6 are cancelled or inactive.

The CIN (Corporate Identification Number) of Tulip Lab is U51397MH2004PTC414474. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Tulip Lab has 13 court cases on record: 8 filed by the company and 5 filed against it. 6 are pending. Most are in the high courts.

Tulip Lab was incorporated on 11 March 2004, making it 22+ years old. It is registered with the Registrar of Companies, Mumbai.

Tulip Lab has 3 deals on record (1 rights issue, 1 funding round, 1 secondary share transfer), with disclosed funding of ₹7.99 Cr; the latest was in March 2023.

The peers of Tulip Lab by revenue are Bio Medica Laboratories Limited, Medicamen Organics Limited, Diamond Drugs Private Limited, Klar Sehen Pvt Ltd, Biomax Biotechnics Private Limited and 2 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Rajni Rahul Pandey ceased to be Additional Director on 30 Nov 2021. Rajni Rahul Pandey was appointed as Director on 30 Mar 2021. Arunabh Ramdarsan Thakur ceased to be Director on 30 Sep 2007. Tulip Lab has 5 board changes on record in total.

Yes, Tulip Lab is registered as a small enterprise under Udyam registration (number: UDYAM-MH-18-0126278).

Tulip Lab has 5 MSME Form 1 returns on record between 2019 and 2022, listing 36 overdue payments to 22 micro and small suppliers. The latest return was filed on 30 Apr 2022.